Trials / Completed
CompletedNCT01806779
Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 376 (actual)
- Sponsor
- Duke University · Academic / Other
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Previous results from the investigators' Center have shown that combination treatment with Chantix and Zyban is more successful in helping men quit smoking. The investigators hope to replicate these findings with this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chantix | |
| DRUG | Zyban | |
| DRUG | Nicotine patches | All participants will receive 21 mg/24 h dose nicotine (nic.) patches for 1 week. |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2014-12-01
- Completion
- 2015-03-01
- First posted
- 2013-03-07
- Last updated
- 2016-01-18
- Results posted
- 2015-10-08
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01806779. Inclusion in this directory is not an endorsement.